Live feed
Filing
SC 13G
SC 13G0001193125-19-277660·Link Fund Solutions Ltd
Schedule 13G ownership disclosure
THERAVANCE BIOPHARMA INC
Security class unavailable · CUSIP: G8807B106
Event date: 2019-10-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.2700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-277660
- Form type
- SC 13G
- Filer
- Link Fund Solutions Ltd
- CIK
- CIK 1792424
- Filed
- Oct 29, 2019
- Reporting period
- Oct 15, 2019
- Description
- Schedule 13G beneficial ownership